MIR424 Gene

HGNC Family Non-coding RNAs
Name microRNA 424
Description microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nRecent studies have revealed that miR‑424 plays a pivotal role in vascular homeostasis and hypoxic adaptation. In endothelial cells, hypoxia‐induced miR‑424 targets key components of the ubiquitin–proteasomal machinery—specifically by suppressing cullin 2—to stabilize HIF‑1α and thereby promote angiogenesis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " Moreover, in pulmonary arterial endothelial cells the miR‑424/503 cluster modulates fibroblast growth factor (FGF) signaling by directly targeting FGF2 and FGFR1, an action that is essential for maintaining vascular integrity and preventing pulmonary hypertension; similar regulatory contributions have also been observed in mediating cross‐talk between the vascular endothelium and cardiomyocytes."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn the realm of cancer biology, miR‑424 has emerged as a central regulator with context‑dependent tumor‐suppressive and oncogenic functions. In several malignancies – including cervical, endometrial, hepatocellular, and basal‑like breast cancers – miR‑424 is frequently downregulated, and its loss contributes to unchecked proliferation, chemoresistance, and impaired apoptosis by failing to restrain key cell cycle and survival regulators such as checkpoint kinase 1, Akt–E2F signaling components, and E2F7."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "5", "end_ref": "9"}]}, {"type": "t", "text": " Furthermore, miR‑424 directly targets transcripts such as those encoding Akt3, E2F3, and the transcription factor PBX3, whose deregulation contributes to the maintenance of tumor‑initiating cells (TICs) in hepatocellular carcinoma."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": " In addition, long noncoding RNAs—including OIP5‑AS1 and PVT1—exert oncogenic effects in cervical cancer by sponging miR‑424, thereby relieving suppression of their downstream targets, while in ovarian and triple‑negative breast cancers, restoration of miR‑424 levels reverses chemoresistance and modulates immune checkpoints such as PD‑L1."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "12", "end_ref": "16"}]}, {"type": "t", "text": " In prostate cancer, however, miR‑424 upregulation impairs the function of an E3 ubiquitin ligase (COP1), leading to enhanced stabilization of oncogenic STAT3 and promoting malignant traits; similarly, in basal‑like breast cancer, miR‑424 suppresses cell proliferation, migration, and invasion via targeting DCLK1, and in osteosarcoma it acts by repressing cyclin A2 expression."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "17", "end_ref": "19"}]}, {"type": "t", "text": " Notably, in non‑small‑cell lung cancer, pharmacological modulation of miR‑424‑3p levels has been shown to affect the PTEN/PI3K/Akt signaling cascade and alter cisplatin sensitivity."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "20"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its roles in vascular regulation and tumor biology, miR‑424 is also intimately involved in cellular differentiation and tissue homeostasis. In myoblasts, induction of the miR‑424/503 cluster promotes G1 cell cycle arrest and facilitates muscle differentiation through downregulation of Cdc25A."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "21"}]}, {"type": "t", "text": " In the placenta, elevated miR‑424 levels are correlated with fetal growth restriction, concomitant with reduced expression of MEK1 and FGFR1, suggesting that miR‑424 contributes to placental developmental processes."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "22"}]}, {"type": "t", "text": " Additionally, miR‑424 has been implicated in the regulation of protein synthesis in skeletal muscle, being elevated in conditions such as chronic obstructive pulmonary disease and even proposed as a potential biomarker in neuromuscular disorders."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "23"}]}, {"type": "t", "text": " Finally, delivery of miR‑424‑5p via extracellular vesicles has been demonstrated to modulate antitumor immune responses by impacting PD‑L1 expression, highlighting its therapeutic potential in immunomodulation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "25"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Goutam Ghosh, Indira V Subramanian, Neeta Adhikari, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-α isoforms and promotes angiogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI42980"}], "href": "https://doi.org/10.1172/JCI42980"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20972335"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20972335"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Aránzazu Chamorro-Jorganes, Elisa Araldi, Luiz O F Penalva, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-16 and microRNA-424 regulate cell-autonomous angiogenic functions in endothelial cells via targeting vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arterioscler Thromb Vasc Biol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/ATVBAHA.111.236521"}], "href": "https://doi.org/10.1161/ATVBAHA.111.236521"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21885851"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21885851"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Jongmin Kim, Yujung Kang, Yoko Kojima, et al. "}, {"type": "b", "children": [{"type": "t", "text": "An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Med (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nm.3040"}], "href": "https://doi.org/10.1038/nm.3040"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23263626"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23263626"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Rui Baptista, Carla Marques, Steve Catarino, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-424(322) as a new marker of disease progression in pulmonary arterial hypertension and its role in right ventricular hypertrophy by targeting SMURF1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cardiovasc Res (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/cvr/cvx187"}], "href": "https://doi.org/10.1093/cvr/cvx187"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29016730"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29016730"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "J Xu, Y Li, F Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2012.121"}], "href": "https://doi.org/10.1038/onc.2012.121"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22469983"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22469983"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Ying Zhang, Tao Li, Pengbo Guo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-424-5p reversed epithelial-mesenchymal transition of anchorage-independent HCC cells by directly targeting ICAT and suppressed HCC progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep06248"}], "href": "https://doi.org/10.1038/srep06248"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25175916"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25175916"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Quan Li, Xiang-Mei Qiu, Qing-Han Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-424 may function as a tumor suppressor in endometrial carcinoma cells by targeting E2F7."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2015.3812"}], "href": "https://doi.org/10.3892/or.2015.3812"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25708247"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25708247"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "David J Drasin, Anna L Guarnieri, Deepika Neelakantan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-14-2394"}], "href": "https://doi.org/10.1158/0008-5472.CAN-14-2394"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25716682"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25716682"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Michiko Yoshida, Kenji Hata, Rikako Takashima, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The transcription factor Foxc1 is necessary for Ihh-Gli2-regulated endochondral ossification."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms7653"}], "href": "https://doi.org/10.1038/ncomms7653"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25808752"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25808752"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Hao Yang, Wei Zheng, Xiao Shuai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-424 inhibits Akt3/E2F3 axis and tumor growth in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.4811"}], "href": "https://doi.org/10.18632/oncotarget.4811"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26315541"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26315541"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Haibo Han, Yantao Du, Wei Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PBX3 is targeted by multiple miRNAs and is essential for liver tumour-initiating cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms9271"}], "href": "https://doi.org/10.1038/ncomms9271"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26420065"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26420065"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Jiyoung Kim, Kotb Abdelmohsen, Xiaoling Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA OIP5-AS1/cyrano sponges RNA-binding protein HuR."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nucleic Acids Res (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/nar/gkw017"}], "href": "https://doi.org/10.1093/nar/gkw017"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26819413"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26819413"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Kenneth Lay, Tsutomu Kume, Elaine Fuchs "}, {"type": "b", "children": [{"type": "t", "text": "FOXC1 maintains the hair follicle stem cell niche and governs stem cell quiescence to preserve long-term tissue-regenerating potential."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1601569113"}], "href": "https://doi.org/10.1073/pnas.1601569113"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26912458"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26912458"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Ya-Li Gao, Zi-Shen Zhao, Ming-Yun Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long Noncoding RNA PVT1 Facilitates Cervical Cancer Progression via Negative Regulating of miR-424."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Res (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3727/096504017X14881559833562"}], "href": "https://doi.org/10.3727/096504017X14881559833562"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28276314"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28276314"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Shaohua Xu, Zhen Tao, Bo Hai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-424(322) reverses chemoresistance via T-cell immune response activation by blocking the PD-L1 immune checkpoint."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms11406"}], "href": "https://doi.org/10.1038/ncomms11406"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27147225"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27147225"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Lin-Lin Ma, Lin Liang, Dan Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tumor suppressor miR-424-5p abrogates ferroptosis in ovarian cancer through targeting ACSL4."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neoplasma (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4149/neo_2020_200707N705"}], "href": "https://doi.org/10.4149/neo_2020_200707N705"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33038905"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33038905"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Cecilia Dallavalle, Domenico Albino, Gianluca Civenni, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-424 impairs ubiquitination to activate STAT3 and promote prostate tumor progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI86505"}], "href": "https://doi.org/10.1172/JCI86505"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27820701"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27820701"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Jianling Wang, Shibing Wang, Jijun Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-424-5p regulates cell proliferation, migration and invasion by targeting doublecortin-like kinase 1 in basal-like breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2018.03.018"}], "href": "https://doi.org/10.1016/j.biopha.2018.03.018"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29550638"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29550638"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Ritu Shekhar, Priyanka Priyanka, Praveen Kumar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The microRNAs miR-449a and miR-424 suppress osteosarcoma by targeting cyclin A2 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.RA118.005778"}], "href": "https://doi.org/10.1074/jbc.RA118.005778"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30679313"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30679313"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Chunya Lu, Huaqi Wang, Shanshan Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Baicalein inhibits cell growth and increases cisplatin sensitivity of A549 and H460 cells via miR-424-3p and targeting PTEN/PI3K/Akt pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.13556"}], "href": "https://doi.org/10.1111/jcmm.13556"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29392841"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29392841"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Sukumar Sarkar, Bijan K Dey, Anindya Dutta "}, {"type": "b", "children": [{"type": "t", "text": "MiR-322/424 and -503 are induced during muscle differentiation and promote cell cycle quiescence and differentiation by down-regulation of Cdc25A."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Biol Cell (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1091/mbc.e10-01-0062"}], "href": "https://doi.org/10.1091/mbc.e10-01-0062"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20462953"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20462953"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "L Huang, Z Shen, Q Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased levels of microRNA-424 are associated with the pathogenesis of fetal growth restriction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Placenta (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.placenta.2013.04.009"}], "href": "https://doi.org/10.1016/j.placenta.2013.04.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23643257"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23643257"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Martin Connolly, Richard Paul, Roser Farre-Garros, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-424-5p reduces ribosomal RNA and protein synthesis in muscle wasting."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cachexia Sarcopenia Muscle (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcsm.12266"}], "href": "https://doi.org/10.1002/jcsm.12266"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29215200"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29215200"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Helen M T de Andrade, Milena de Albuquerque, Simoni H Avansini, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNAs-424 and 206 are potential prognostic markers in spinal onset amyotrophic lateral sclerosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurol Sci (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jns.2016.06.046"}], "href": "https://doi.org/10.1016/j.jns.2016.06.046"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27538595"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27538595"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Yueyuan Zhou, Yusuke Yamamoto, Fumitaka Takeshita, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Delivery of miR-424-5p via Extracellular Vesicles Promotes the Apoptosis of MDA-MB-231 TNBC Cells in the Tumor Microenvironment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms22020844"}], "href": "https://doi.org/10.3390/ijms22020844"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33467725"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33467725"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Narges Dastmalchi, Mohammad Ali Hosseinpourfeizi, Seyed Mahdi Banan Khojasteh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Life Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.lfs.2020.118239"}], "href": "https://doi.org/10.1016/j.lfs.2020.118239"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32784058"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32784058"}]}]}]}
Synonyms MIRNA424, HSA-MIR-424, MIR-424, MIRN424, MIR322
NCBI Gene ID 494336
API
Download Associations
Predicted Functions View MIR424's ARCHS4 Predicted Functions.
Co-expressed Genes View MIR424's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View MIR424's ARCHS4 Predicted Functions.

Functional Associations

MIR424 has 789 functional associations with biological entities spanning 6 categories (molecular profile, disease, phenotype or trait, functional term, phrase or reference, chemical, cell line, cell type or tissue, gene, protein or microRNA) extracted from 17 datasets.

Click the + buttons to view associations for MIR424 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR424 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR424 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of MIR424 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR424 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
CTD Gene-Disease Associations diseases associated with MIR424 gene/protein from the curated CTD Gene-Disease Associations dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR424 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR424 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of MIR424 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with MIR424 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing MIR424 from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of MIR424 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of MIR424 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR424 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of MIR424 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of MIR424 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR424 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
WikiPathways Pathways 2014 pathways involving MIR424 protein from the Wikipathways Pathways 2014 dataset.